Showing 41 - 60 results of 169 for search '"Безопасность и риск фармакотерапии"', query time: 0.05s Refine Results
  1. 41
    Signal Management: Updated Requirements of the EAEU Good Pharmacovigilance Practice

    Signal Management: Updated Requirements of the EAEU Good Pharmacovigilance Practice by A. V. Matveev, A. E. Krasheninnikov, A. Yu. Zelinskaya

    Published 2023-03-01
    “…Безопасность и риск фармакотерапии…”
    Get full text
    Article
    Save to List
    Saved in:
  2. 42
    Approaches to Assessing the Safety of Medicines during the COVID-19 Pandemic Using the Example of Azithromycin

    Approaches to Assessing the Safety of Medicines during the COVID-19 Pandemic Using the Example of Azithromycin by Yu. M. Gomon, A. R. Kasimova, A. S. Kolbin, V. V. Strizheletsky, I. G. Ivanov, S. O. Mazurenko

    Published 2022-10-01
    “…Безопасность и риск фармакотерапии…”
    Get full text
    Article
    Save to List
    Saved in:
  3. 43
    Submission of Documents on the Pharmacovigilance System as Part of the Registration Dossier within the Framework of the EAEU Procedures: Analysis of Requirements and Typical Errors

    Submission of Documents on the Pharmacovigilance System as Part of the Registration Dossier within the Framework of the EAEU Procedures: Analysis of Requirements and Typical Errors by N. Yu. Velts, E. O. Zhuravleva, G. V. Kutekhova, N. V. Tereshkina

    Published 2024-10-01
    “…Безопасность и риск фармакотерапии…”
    Get full text
    Article
    Save to List
    Saved in:
  4. 44
    In Silico Prediction of Toxicological and Pharmacokinetic Characteristics of Medicinal Compounds

    In Silico Prediction of Toxicological and Pharmacokinetic Characteristics of Medicinal Compounds by P. M. Vassiliev, A. V. Golubeva, A. R. Koroleva, M. A. Perfilev, A. N. Kochetkov

    Published 2023-12-01
    “…Безопасность и риск фармакотерапии…”
    Get full text
    Article
    Save to List
    Saved in:
  5. 45
    Thrombocytopenia as a Side Effect of Heparin Therapy and COVID-19 Vaccination: A Review

    Thrombocytopenia as a Side Effect of Heparin Therapy and COVID-19 Vaccination: A Review by S. S. Postnikov, N. V. Teplova, O. V. Gulbekova

    Published 2025-06-01
    “…Безопасность и риск фармакотерапии…”
    Get full text
    Article
    Save to List
    Saved in:
  6. 46
    Recommendations on Informational Monitoring of the Safety and Efficacy of Medicinal Products in the Russian Federation as Part of Pharmacovigilance

    Recommendations on Informational Monitoring of the Safety and Efficacy of Medicinal Products in the Russian Federation as Part of Pharmacovigilance by K. S. Milchakov

    Published 2022-10-01
    “…Безопасность и риск фармакотерапии…”
    Get full text
    Article
    Save to List
    Saved in:
  7. 47
    New Technologies in Electronic Pharmacovigilance Systems for Marketing Authorisation Holders

    New Technologies in Electronic Pharmacovigilance Systems for Marketing Authorisation Holders by O. A. Loginovskaya, V. P. Kolbatov, R. V. Sukhov, M. S. Ryavkina, A. S. Kolbin

    Published 2022-10-01
    “…Безопасность и риск фармакотерапии…”
    Get full text
    Article
    Save to List
    Saved in:
  8. 48
    The Effect of Potentially Hepatotoxic Medicinal Products on Alanine Transaminase Levels in COVID-19 Patients: A Case–Control Study

    The Effect of Potentially Hepatotoxic Medicinal Products on Alanine Transaminase Levels in COVID-19 Patients: A Case–Control Study by V. I. Petrov, A. Yu. Ryazanova, N. S. Tokareva

    Published 2025-06-01
    “…Безопасность и риск фармакотерапии…”
    Get full text
    Article
    Save to List
    Saved in:
  9. 49
    Safety of Lipid-Lowering Therapy with Statins according to a Regional Pharmacovigilance Centre

    Safety of Lipid-Lowering Therapy with Statins according to a Regional Pharmacovigilance Centre by E. O. Kochkina, N. V. Verlan

    Published 2023-09-01
    “…Безопасность и риск фармакотерапии…”
    Get full text
    Article
    Save to List
    Saved in:
  10. 50
    Malnutrition in Elderly Patients as a Complication of a Drug Therapy: Clinical Pharmacologist’s Point of View

    Malnutrition in Elderly Patients as a Complication of a Drug Therapy: Clinical Pharmacologist’s Point of View by A. P. Pereverzev, O. N. Tkacheva, Y. V. Kotovskaya, O. D. Ostroumova

    Published 2019-03-01
    “…Безопасность и риск фармакотерапии…”
    Get full text
    Article
    Save to List
    Saved in:
  11. 51
    The revision of the restrictive lists of medicinal products

    The revision of the restrictive lists of medicinal products by B. K. Romanov, Yu. V. Olefir, V. A. Merkulov, Y. O. Pegova

    Published 2018-02-01
    “…Безопасность и риск фармакотерапии…”
    Get full text
    Article
    Save to List
    Saved in:
  12. 52
    Safety Pharmacology Study of Medicines Used for Febrile Syndrome Management in Children

    Safety Pharmacology Study of Medicines Used for Febrile Syndrome Management in Children by K. L. Kryshen, A. E. Moshkov, M. N. Demyanovskiy, M. A. Kovaleva

    Published 2020-09-01
    “…Безопасность и риск фармакотерапии…”
    Get full text
    Article
    Save to List
    Saved in:
  13. 53
    Digital Pharmacotherapy Support for Medication Adherence

    Digital Pharmacotherapy Support for Medication Adherence by S. A. Zaveryachev, E. E. Lotnik, M. A. Gilavyan, E. A. Yusupovskaya, K. A. Koshechkin

    Published 2023-12-01
    “…Безопасность и риск фармакотерапии…”
    Get full text
    Article
    Save to List
    Saved in:
  14. 54
    Medication errors

    Medication errors by B. K. Romanov, I. A. Toropova, E. Y. Kolesnikova

    Published 2022-06-01
    “…Безопасность и риск фармакотерапии…”
    Get full text
    Article
    Save to List
    Saved in:
  15. 55
    PCSK9 Monoclonal Antibodies for the Primary and Secondary Prevention of Cardiovascular Disease

    PCSK9 Monoclonal Antibodies for the Primary and Secondary Prevention of Cardiovascular Disease by article Editorial

    Published 2023-12-01
    “…Безопасность и риск фармакотерапии…”
    Get full text
    Article
    Save to List
    Saved in:
  16. 56
    On the interchangeability of calcineurine inhibitors

    On the interchangeability of calcineurine inhibitors by K. E. Zatolochina, R. N. Alyautdin, E. O. Zhuravleva, E. Yu. Pasternak, M. A. Darmostukova, E. Yu. Kolesnikova, B. K. Romanov

    Published 2018-02-01
    “…Безопасность и риск фармакотерапии…”
    Get full text
    Article
    Save to List
    Saved in:
  17. 57
    Monitoring of drug safety

    Monitoring of drug safety by B. K. Romanov, S. V. Glagolev, V. A. Polivanov, M. V. Leonova

    Published 2022-06-01
    “…Безопасность и риск фармакотерапии…”
    Get full text
    Article
    Save to List
    Saved in:
  18. 58
    Gene Therapy Medicinal Products: Non-clinical Safety Studies

    Gene Therapy Medicinal Products: Non-clinical Safety Studies by O. V. Astapova, A. A. Berchatova

    Published 2023-03-01
    “…Безопасность и риск фармакотерапии…”
    Get full text
    Article
    Save to List
    Saved in:
  19. 59
    Problematic aspects of participation of pharmacists in the system of pharmacovigilance in Russia

    Problematic aspects of participation of pharmacists in the system of pharmacovigilance in Russia by E. N. Tkhoseva, T. E. Morozova, O. A. Vartanova, S. M. Rykova, T. B. Andruschishina, D. A. Ermakov, S. M. Oshorova

    Published 2022-06-01
    “…Безопасность и риск фармакотерапии…”
    Get full text
    Article
    Save to List
    Saved in:
  20. 60
    Preparation for the Inspection of the Pharmacovigilance System

    Preparation for the Inspection of the Pharmacovigilance System by B. K. Romanov

    Published 2021-10-01
    “…Безопасность и риск фармакотерапии…”
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: